In this interview Sune Klint Andersen,Principal Scientist in Drying Processes and Particle Technology in CMC at Novo Nordisk A/S, Denmark, shares his future perspectives on process analytical technology (PAT) & quality by design (QbD) utilisation. Klint Andersen also discusses what impact QbD has on process understanding, product development and product quality and the main challenges encountered when adopting QbD.
Pharma IQ: What is meant by Quality by Design and what are the key busi...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 01 - 03, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More